A Patient with GOLD Stage 3 COPD « cured » by One-Way Endobronchial Valves
Lung hyperinflation is a main determinant of dyspnoea in patients with chronic obstructive pulmonary disease (COPD). Surgical or bronchoscopic lung volume reduction are the most efficient therapeutic approaches for reducing hyperinflation in selected patients with emphysema. We here report the case...
Main Authors: | Eric Marchand, Jean-Paul d’Odemont, Michael V Dupont |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Medicina |
Subjects: | |
Online Access: | http://www.mdpi.com/1010-660X/55/3/65 |
Similar Items
-
The National Institute for Health and Care Excellence (NICE) Updated Guidance on Endobronchial Valves: What Was Behind the Decision and What Does it Mean for Pulmonologists?
by: Pallav L. Shah
Published: (2018-11-01) -
Endobronchial Valve Replacements in Patients with Advanced Emphysema After Endoscopic Lung Volume Reduction
by: Brock JM, et al.
Published: (2023-05-01) -
Endobronchial one‐way valve for persistent air leak and lung volume reduction
by: Wai Cho Yu, et al.
Published: (2019-10-01) -
Which Endoscopic Procedure to Use and in What Patient? Valves, Coils, Foam, and Heat in COPD and Asthma
by: Andrew Li, et al.
Published: (2022-12-01) -
Early Spirometry Following Bronchoscopic Lung Volume Reduction with Endobronchial Valves
by: Pascal Bezel, et al.
Published: (2022-01-01)